跳至主要内容
临床试验/EUCTR2013-001850-83-FR
EUCTR2013-001850-83-FR进行中(未招募)1 期

Adaptation to neonatal life after an anesthetic protocol using remifentanil for general anesthesia for caesarean section in a context of prematurity - REAGI Protocol (Remifentanil for General Anesthesia in the context of Immaturity) - REAGI

CHU- Hôpitaux de Rouen0 个研究点目标入组 60 人开始时间: 2015年9月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria of the mother:
  • - Patient over 18 years
  • - Single pregnancy with an indication for cesarean section under general anesthesia context of prematurity (<37SA)
  • - Patient informed and written consent for participation in this research signed
  • - Affiliation to social security
  • Inclusion criteria of the child:
  • Parents informed and written consent signed by the father and mother for the participation in this research by the child (unless a parent no longer has parental authority)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Non-inclusion criteria of the mother:
  • - Vaginal Delivery
  • - Mother pathology requiring the use of an opioid during induction
  • - Severe Preeclampsia
  • - More than 14 weeks between the information and the inclusion
  • - Patient under guardianship
  • Non-inclusion criteria of the child:
  • Fetal pathology diagnosed in the prenatal period involving the prognosis of the child

研究者

发起方
CHU- Hôpitaux de Rouen

相似试验